These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2580184)

  • 1. Effect of chronic nifedipine in patients inadequately controlled by a converting enzyme inhibitor and a diuretic.
    Mimran A; Ribstein J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S92-5. PubMed ID: 2580184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nifedipine in hypertension not controlled by converting enzyme inhibitor and diuretic.
    Mimran A; Ribstein J
    Postgrad Med J; 1986; 62 Suppl 1():135-8. PubMed ID: 3022271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.
    Havelka J; Vetter H; Studer A; Greminger P; Lüscher T; Wollnik S; Siegenthaler W; Vetter W
    Am J Cardiol; 1982 Apr; 49(6):1467-74. PubMed ID: 6280477
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
    Chan JC; Nicholls MG; Cheung CK; Law LK; Swaminathan R; Cockram CS
    Diabetes Care; 1995 Jul; 18(7):1001-6. PubMed ID: 7555530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kalemia during combined therapy with an angiotensin converting enzyme inhibitor and a potassium-sparing diuretic.
    Mooser V; Waeber G; Bidiville J; Waeber B; Nussberger J; Brunner HR
    J Clin Hypertens; 1987 Dec; 3(4):510-3. PubMed ID: 2839627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative pilot study of enalapril, a new converting enzyme inhibitor, and hydrochlorothiazide in essential hypertension.
    Ferguson RK; Vlasses PH; Irvin JD; Swanson BN; Lee RB
    J Clin Pharmacol; 1982 Jul; 22(7):281-9. PubMed ID: 6286734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
    Baumgart P; Tenschert W; Vetter H
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and nifedipine in combination for moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    Hypertension; 1987 Jun; 9(6):629-33. PubMed ID: 3294594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive treatment using calcium antagonists in combination with captopril rather than diuretics.
    Brouwer RM; Bolli P; Erné P; Conen D; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S88-91. PubMed ID: 2580183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide.
    Singer DR; Markandu ND; Sugden AL; Miller MA; MacGregor GA
    Hypertension; 1991 Jun; 17(6 Pt 1):798-803. PubMed ID: 2045142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting enzyme inhibitors in essential hypertensives.
    Takata Y; Yoshizumi T; Ito Y; Ueno M; Tsukashima A; Iwase M; Kobayashi K; Fujishima M
    Am Heart J; 1992 Dec; 124(6):1574-80. PubMed ID: 1462917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.
    Guazzi MD; De Cesare N; Galli C; Salvioni A; Tramontana C; Tamborini G; Bartorelli A
    Circulation; 1984 Aug; 70(2):279-84. PubMed ID: 6375889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine.
    MacGregor GA; Markandu ND; Smith SJ; Sagnella GA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S82-7. PubMed ID: 2580182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril worldwide experience.
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Am J Med; 1984 Aug; 77(2A):23-35. PubMed ID: 6089556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.